Follow‐up after oral cancer treatment—Transition to a personalized approach

Brands, Marieke T.; Verbeek, A.L.M.; Geurts, S.M.E.; Merkx, Matthias A.W.

doi:10.1111/jop.13147

Cited by 4 publications

(4 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The lack of compliance with dental follow-up programmes and the paucity of information provided to patients, regarding the side effects of cancer treatments, emerged during the various iCAN meetings. This highlighted the need to develop personalized and multidisciplinary follow-up programmes, as also advocated by Brands et al (2021) who have examined ways of optimizing routine follow-up programmes in patients being treated for oral cancer. In supporting patients, the authors created a patient information leaflet with current guidelines regarding oral mucositis, which is the most common side effect of cancer treatments ( Elad et al, 2020 ).…”

Section: Discussionmentioning

confidence: 99%

Improving the cancer adult patient support network (iCAN): a pilot study on a communication model and modified focus group

Campisi,

Bazzano,

Mauceri

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

BackgroundMany consider that cancer has the greatest impact of any disease in the world, and it can drastically limit patients’ quality of life. Combating such a life-threatening disease can pose many challenges to daily life, highlighted by demonstrating the need to discuss one’s health status within a focus group and encourage treatment compliance.Aimthe purposes of this study were to share the authors’ experience of a modified focus group in an Oral Medicine Unit, termed “Improving Cancer Adult Patients Support Network” (iCAN), and to evaluate how effective communication could improve patients’ quality of life and empower them by virtue of enhanced knowledge and an awareness of cancer management.Methodsthe paper adhered to the COREQ checklist regarding its reporting procedures. The iCAN format was precisely reproduced four times with four groups, consisting of 12 adult male and female patients with solid cancers. They discussed several main topics relating to cancer treatment, as chosen by a majority of the participants. Four specialists were involved in the discussion of the selected topics The iCAN format was faithfully reproduced during each meeting, with the participants in the roles of moderator and health specialists. Finally, a satisfaction questionnaire was administered.Resultsthe most reliable results demonstrated a marked change in lifestyle and eating habits in more than 50% of participants. More than 80% were unaware of the side effects of cancer treatments in general and the oral mucosa in particular. Each meeting reported a maximum degree of satisfaction experienced by the participants.ConclusioniCAN focus group meetings appear to have facilitated a process of narrative interviewing, thereby improving the doctor-patient relationship underlying the humanization of the care process.

show abstract

Section: Discussionmentioning

confidence: 99%

Improving the cancer adult patient support network (iCAN): a pilot study on a communication model and modified focus group

Campisi,

Bazzano,

Mauceri

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

show abstract

“…The lack of survival benefit from follow-up forces us to re-evaluate follow-up and this conclusion has also been drawn for other sublocations of the head and neck area. 21 Routine check-ups do not only provide benefits and reassurance, but could also be a burden for patients. They may cause psychosocial and physical harm in healthy patients due to anxiety, fear of cancer recurrence and as a result of false positive findings leading to unnecessary treatment and unnecessary tests.…”

Section: Discussionmentioning

confidence: 99%

“…In our population, 755 routine visits have been performed to detect one asymptomatic new LR/HNSCC, without clear survival benefit. The lack of survival benefit from follow‐up forces us to re‐evaluate follow‐up and this conclusion has also been drawn for other sublocations of the head and neck area 21 . Routine check‐ups do not only provide benefits and reassurance, but could also be a burden for patients.…”

Section: Discussionmentioning

confidence: 99%

Value of routine follow‐up in oropharyngeal squamous cell cancer patients treated with curative intent

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background The major goal of routine follow‐up in oropharyngeal squamous cell carcinoma (OPSCC) patients is the asymptomatic detection of new disease in order to improve survival. This study evaluated the effect of routine follow‐up on overall survival (OS). Methods A retrospective cohort of 307 consecutive OPSCC patients treated with curative intent between 2006 and 2012 was analyzed. The effectiveness of routine follow‐up was studied by comparing treatment‐intent and OS in patients with asymptomatically versus symptomatically detected new disease. Results Three‐ and five‐year risks of new disease were 29% (95% CI: 24–34) and 33% (95% CI: 27–39). Of the 81 patients with locoregional recurrence or second primary head and neck cancer, 8 (10%) were detected asymptomatically with no difference in OS with those detected with symptoms. Conclusions Asymptomatic detection of new disease during routine visits was not associated with improved OS. The focus of follow‐up should be on providing psychosocial care and rehabilitation.

show abstract

“…Risk-stratified follow-up is also recommended in HNC [ 5 , 9 , 13 , 17 , 35 ], e.g. de-intensified follow-up for lower risk of recurrence [ 13 , 36 , 37 ].…”

Section: Introductionmentioning

confidence: 99%

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

et al. 2022

View full text Add to dashboard Cite

Aims: Current follow-up for head and neck cancer (HNC) is ineffective, expensive and fails to address patients' needs. The PETNECK2 trial will compare a new model of patient-initiated follow-up (PIFU) with routine scheduled follow-up. This article reports UK clinicians' views about HNC follow-up and PIFU, to inform the trial design. Materials and methods: Online focus groups with surgeons (ear, nose and throat/maxillofacial), oncologists, clinical nurse specialists and allied health professionals. Clinicians were recruited from professional bodies, mailing lists and personal contacts. Focus groups explored views on current follow-up and acceptability of the proposed PIFU intervention and randomised controlled trial design (presented by the study co-chief investigator), preferences, margins of equipoise, potential organisational barriers and thoughts about the content and format of PIFU. Data were interpreted using inductive thematic analysis. Results: Eight focus groups with 34 clinicians were conducted. Clinicians highlighted already known limitations with HNC follow-up e lack of flexibility to address the wide-ranging needs of HNC patients, expense and lack of evidence e and agreed that follow-up needs to change. They were enthusiastic about the PETNECK2 trial to develop and evaluate PIFU but had concerns that PIFU may not suit disengaged patients and may aggravate patient anxiety/fear of recurrence and delay detection of recurrence. Anticipated issues with implementation included ensuring a reliable route back to clinic and workload burden on nurses and allied health professionals. Conclusions: Clinicians supported the evaluation of PIFU but voiced concerns about barriers to help-seeking. An emphasis on patient engagement, psychosocial issues, symptom reporting and reliable, quick routes back to clinic will be important. Certain patient groups may be less suited to PIFU, which will be evaluated in the trial. Early, meaningful, ongoing engagement with clinical teams and managers around the trial rationale and recruitment process will be important to discourage selective recruitment and address risk-averse behaviour and potential workload burden.

show abstract

Follow‐up after oral cancer treatment—Transition to a personalized approach

Cited by 4 publications

References 43 publications

Improving the cancer adult patient support network (iCAN): a pilot study on a communication model and modified focus group

Improving the cancer adult patient support network (iCAN): a pilot study on a communication model and modified focus group

Value of routine follow‐up in oropharyngeal squamous cell cancer patients treated with curative intent

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

Contact Info

Product

Resources

About